跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,424 条关于
“BeiGene Ltd.”
全部
9,424
临床试验
1,715
药物
1,587
机构
4,111
资讯
2,011
去年
BeiGene Advances Global Cancer Treatment with Innovative Therapies
去年
BeiGene Initiates Phase I Clinical Trial of BGB-A317 in China
2年前
BriaCell and BeiGene Collaborate on Bria-OTS™ and Tislelizumab Combination Therapy for Advanced Breast Cancer
去年
BeiGene Launches Global Phase 2 Trial of Zanubrutinib for Relapsed or Refractory Marginal Zone Lymphoma
2年前
Esophageal Cancer Clinical Trial Landscape Shows Surge in Global Research and Investment
去年
Repare Therapeutics' Gynecological Cancer Trial Shows Mixed Results, Beigene Inks $1.5B Deal for MAT2A Inhibitor
去年
FDA Approves Jazz Pharmaceuticals' Ziihera for HER2-Positive Biliary Tract Cancer
2年前
Tislelizumab Approved in Europe for Non-Small Cell Lung Cancer Treatment
2年前
Jazz Pharmaceuticals Completes FDA Submission for Zanidatamab in HER2-Positive Biliary Tract Cancer
去年
Jazz Pharmaceuticals Advances Pipeline with Zanidatamab BLA Acceptance and Strong Financial Performance
第 1 页,共 202 页
上一页
下一页